Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Sean, I received a response from Arian Colachis, c

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154604
(Total Views: 532)
Posted On: 05/06/2021 1:19:25 PM
Posted By: HCIT
Re: sean007 #89162
Sean, I received a response from Arian Colachis, council for CYDY and she said what I said that the technical difficulties they had during the website call yesterday limited some of the questions not being answered so here is her response.
__________________________________________________
"Mr. XXXXX,

Your questions came in after the call (I am saying NOPE, b4 the call) and unfortunately the Company cannot respond to questions from investors except in a public format. We will keep these questions for our next investment community call, and thank you for your good wishes.

Arian Colachis
SVP, General Counsel & Corporate Secretary
CytoDyn Inc. (http://www.cytodyn.com/)
1111 Main Street, Suite 660
Vancouver, Washington 98660
E-mail: acolachis@cytodyn.com
Office: (360) 998-3992
Facsimile: (360) 799-5954
Mobile: (206) 235-6737

NOTICE: This communication may contain privileged or other confidential information. If you have received it in error, please advise the sender by reply email and immediately delete the message and any attachments without copying or disclosing the contents. Thank you.
_____________________________________________________
I sent that question Sean 2 hours before the call so maybe they didn't want to answer it or they didn't want anyone to know that they might not have the answers for that question. IDK, maybe they never gave a thought to collecting that kind of data but to me, it's an important statistic that shows how many caught Covid or DIDN'T catch Covid b/c they were already receiving Leronlimab which to me could be an outstanding statistic, do you agree?

GLTU

HCIT


(2)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  


https://media.gettyimages.com/photos/the-grea...wdoE_swYM=




Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us